Medical Staff

Progress Notes
From the
President
At its April
meeting, the Medical Executive
Committee voted on several important
issues. The committee endorsed the
Board of Trustees' reports on
Education and Chairpersons. These
two documents express the direction
and intent the Board envisions for our
hospital. As previously noted, these
documents have been available in the
Medical Staff Office; however, as the
contents of these documents are
important for our active :¥edical Staff,
copies will be provided at the next
General Medical Staff meeting.
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The Medical Executive Committee also
voted to remove itself from the process
of reviewing and making
recommendations concerning requests
for Medical Staff Development slots.
We struggled to this conclusion after
considering the tangled deliberations of
the Medical Executive Committee
when reviewing slots/slot applications.
The department chairperson would
solicit input from his division and
make his recommendations (as well as
the division recommendations, if
contrary) to a group consisting of the
11 departmental chairpersons, the
hospital CEO, COO, Chief of Clinical
Services, hospital counsel, Vice
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President for Medical Staff Services,
and members of TROIKA. A report
from this group would be sent to the
Medical Executive Committee for
informational purposes and sent
directly to the Quality
Assurance/Medical Allied Health Staff
Development Committee of the Board
which would then submit its
recommendations to the Board of
Trustees.
A modification of the so called two
year rule was also passed.
Immediately upon receipt of
notification from a private practice
group that an individual has been
involuntarily terminated from the
group, or when an individual is no
longer employed under a contract with
the hospital, that individual would lose
medical staff privileges and
membership. These individuals would,
however, be permitted to request a slot
within 60 days of such notification,
requiring immediate consideration by
the new hospital group mentioned
above, the Quality Assurance/Medical
Allied Staff Development Committee of
the Board, and the Board of Trustees at
their next scheduled meeting.
Voluntary termination from either
private practice groups or hospital
contracts will be reviewed only during
the normal Semiannual Needs Survey
cycle.
Continued on Page 2

Continued from Page 1

The Medical Staff Development Plan
has been a source of much

consternation in its individual
application. The general principles of
the plan, however, remain an important
document which the Medical Staff,
through the Medical Executive
Committee, must maintain input and
provide insight. In that regard, we
will be reviewing those principles in a
upcoming meeting of the Medical
Executive Committee.
Finally, a quick update on the
Managed Care initiative. The first
draft of the Business Plan has been
completed, and TROIKA reviewed it
with Dan Grauman of the Raleigh
Group. It is being distributed to our

Managed care Committee for further
discussion and revision. We have been
very active in formulating our plan at a
rapid pace. The issue of capitation/
gatekeeper concept also needs to be
faced if we are to be perched
competitively in the managed care
arena. A group of primary care
practitioners and Tom Hansen, Senior
Vice President, are grappling with this
issue.
Best wishes,

I..i:::

CandioM.D.
President, Medical Staff

At-Large Members Needed for Medical Executive
Committee
The Medical Staff Nominations
Committee is soliciting nominations for
four at-large seats, each for a threeyear term beginning July 1, 1993, on
the Medical Executive Committee.

If you have any questions regarding
this issue, please contact Dr. Castaldo
or Mr. Hart at 402-8968.

Nominations should be submitted in
writing to John E. Castaldo, M.D.,
Chairman of the Nominating
Committee, via the Medical Staff
Services Office, Cedar Crest & 1-78,
or verbally to Joseph A. Candio,
M.D., Medical Staff President, John
Jaffe, M.D., Past President, Medical
Staff, or John W. Hart, Vice President.
All nominations must be submitted
prior to June 1, 1993.
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Physician Parking Changes- Cedar Crest & 1-78
Effective Monday, May 17, 1993,
physician parking was expanded and
temporarily relocated to a new lot
which provides physicians with over 30
new spaces (please refer to the map on
page 16). The new lot is gated and
card accessible as it has been in the
past.
Additionally, the relocation and
expansion of physician parking
provides an increased number of
patient parking spaces in response to
the growing demand from patients of
the 1210 Medical Office Building.

)

The relocation of physician parking is
timely because of an upcoming
construction project that will displace
many spaces in the current physician
lot. In June, temporary trenching will
occur so that pipework can be laid to
connect the hospital boiler system to
the John and Dorothy Morgan Cancer
Center. The trenching will pass
through the former physician lot
(please refer to the map).

After the trench work is completed, the
parking spaces formerly occupied by
physicians will be dedicated to
accommodate the additional patient
parking needed. It is anticipated that
physician parking will return to the
original lot upon completion of the
Dorothy and John Morgan Cancer
Center.
Thank you for your continued
cooperation since the early stages of
the construction for the John and
Dorothy Morgan Cancer Center. In
particular, a special thank you to the
tenants of 1210, 1220 and 1230 S.
Cedar Crest Blvd., for their patience
with regards to parking and other
issues that have affected them during
this time.
If you have any questions regarding
this issue, please contact either John
W. Hart, Vice President, or Joseph A.
Candio, M.D., Medical Staff
President, at 402-8968.

Physician Hotline for Patient Census
Effective May 8,
the date of
PHAMIS
"Go-Uve," the
telephone number
402-4508 will be
manned and accepting calls from
physicians who wish to inquire as to
the daily census of their patients at
both sites of Lehigh Valley Hospital.

Information Services is pleased to
support this request, and will be
automating the process as soon as
possible, offering fax service and
computer notification directly off the
computer mainframe. Unfortunately,
availability of these services is not
anticipated for at least 60 to 90 days,
but it is hoped that this telephone
number and staffing will be helpful.
Pagel

Laboratory
Update

News from the
Microbiology Division

a

Sporadically, the Microbiology
Division of Health Network
Laboratories receives urine specimens
obtained by "suprapubic" collection.
When these are received, the
laboratorian must call the nursing unit
in order to establish whether the
specimen was collected by suprapubic
"aspiration" or "catheterization" since
they are processed differently. In
contrast to catheterized specimens,
aspirates are cultured as closed body
site fluids and all organisms isolated
are identified. It has been found,
however, that most, if not all,
specimens received are, in fact,
collected by "suprapubic
catheterization. "

In order to assure that urines collected
by aspiration are processed correctly,
please mark the chart under physician
orders "suprapubic aspirate for C&S"
and submit the specimen in a sterile
Port-A-Cui transport vial. All other
specimens marked as "suprapubic" on
the Microbiology Request Form will be
processed as a catheter collected
specimen.

a

Based on new National Committee
of Clinical Laboratory Standards
(NCCLS M110-S4) recommendations,
the "moderately susceptible" category
for ampicillin and penicillin
susceptibility testing of Enterococcus
spp. has been deleted. There are now
two categories that may be reported,
i.e., "susceptible" and "resistant." The
"susceptible" category for penicillin or
ampicillin implies the need for high
dose therapy for serious enterococcal

infections. According to the NCCLS
guidelines, enterococcal endocarditis
requires combined therapy with high
dose penicillin or high dose ampicillin,
or vancomycin, or teicoplanin plus
gentamicin or streptomycin for
bactericidal action. Detection of
ampicillin or penicillin resistance for
enterococci due to B-lactamase
production is not possible by the
routine disk diffusion or dilution MIC
methods. Therefore, blood and CSF
isolates will be tested using a method
that will detect B-lactamase. We will
continue to screen for aminoglycoside
susceptibility as a means of identifying
isolates that will respond
synergistically to ampicillin or
penicillin and an aminoglycoside.

a

The Microbiology Division of
Health Network Laboratories has
implemented the following policy basa.
on recent reports in the literature
related to inappropriate testing for
diarrheal disease.

o The laboratory performs a
screen for direct Giardia

antigen testing. Since the
greater percentage of specimens
are positive for this parasite, the
lab recommends ordering a
Giardia antigen screen rather
than a comprehensive Ova &
Parasite examination. Orders
must specify Giardia antigen
screen or Comprehensive Ova
& Parasite exam. Specimens
will be stored in the laboratory
for five days following the final
Giardia screen report, before
discarding them.

Continued on Page 5
Page 4

Continued from Page 4

The lab may be contacted
within this five-day period at
402-8190 if further parasite
evaluation is required.
o Only one stool specimen for
ova and parasite should be
submitted in order to document
a parasitic infection. The
previous recommendation
requiring three samples was
based on an old epidemiological
study with asymptomatic
patients. An exception to this
recommendation relates to
intermittent shedding associated
with Giardia Iamblia. If the
Giardia antigen screen is
negative, but you still suspect
this parasite, submit a second
specimen at least three days
after the first specimen for a
repeat Giardia antigen screen.

o Stool specimens for Culture
and Ova and Parasites will not
routinely be processed when
collected from inpatients who
have been hospitaliml for more
than three days. However, if
the epidemiology or clinical
findings, e.g.,
immunocompromised host,
warrant processing of a
specimen submitted more than
three days post-admission,
physicians may contact Georgia
Colasante, Microbiology
Supervisor, at 402-8190, or
Diane C. Halstead, Ph.D.,
Director, Microbiology/
Virology/Immunology/FCM, at
beeper 1193.

Scheduling of Ultrasounds

aRadiology/Diagnostic
Recently' the Department of
Medical Imaging
discontinued obstetrical ultrasound
services. As a result, the previous
backlog of other ultrasound requests,
as long as several weeks at 17th &
Chew, has been eliminated.

)

Routine outpatient ultrasound studies
can now be performed in one or two
days of request at 17th & Chew. In
addition, prostate ultrasound· and
biopsy protocols are now uniform at
both sites. These procedures can be
scheduled with little or no delay at
17th & Chew. To schedule an ultra-

sound at 17th & Chew, call 402-2450;
at Cedar Crest & 1-78, call 402-8080.
If you have any questions regarding
this issue, please contact Thomas R.
Fitzsimons, M.D., radiologist, at
402-2214.

a Obstetrical ultrasounds are now

handled through the Perinatal
Diagnosis Testing Center located in the
Center for Women's Medicine.
Obstetrical ultrasounds may be
scheduled by called 402-9595 (until
May 24). After. May 24, the number
to call for scheduling is 402-7100.
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Library
News

a The Health Sciences Library at

a New acquisitions to the Health

Mayo Clink Ptvceldings - Volume 67

Gabbe. Ob*lrlcs: Nol'llllll tllld
Ptvblem Preg111111CU1. 2nd ed.,
Churchill Livingstone, 1991.

Cedar Crest & I-78 is seeking
donations of the following journals:

115 (May), 16 (June), #7 (July), and #8
(August), 1992.

Joul'lllll of Nru:lear Ml4idae Volume 32 #11 (November), #12
(December), 1991.
Bmergeney Medkine - Volume 23
#14, #15, #18, #20, 1991.
Emergency Medkine- Volume 24 #1,
1992.

a The following journals are now

available in the Computer Laboratory
section of the library:

1

Sciences Library at 17th & Chew
include:

Guyton. HUIIUIIJ PhyliolDgy tllld
Mecluudsm of Dis~~Ue. 5th ed., W.B.
Saunders, 1992.

a Remote Access to Medline is still

going strong. For current information
regarding additional databases
available, contact Sherry Giardiniere at
402-8406.

Conaputen tllld Biomediclll Eductltion
Conaputen cl Ml4idae
M.D. Conaputing
Phyricilm1 tllld Conaputen

Celebration of Life Lehigh Valley Hospital is sponsoring a
Celebration of Ufe to heighten
awareness of the importance of
mammography and to increase patient
awareness of Lehigh Valley Hospital's
women's health services.
The campaign kicked off on May 1
with 20,000 seed boxes mailed to
women ages 40 to 64 in Lehigh Valley
Hospital's primary service area. The

boxes contain a packet of flower seeds,
a booklet on mammography and breast
self examination, and a $10.00
discount off mammography services at
Lehigh Valley Hospital.

Office displays with seed packets are
also being distributed to participating
physician offices specializing in
obstetrics and gynecology, internal
medicine, family practice, and general
surgery.
In July, Comprehensive Breast Services
brochures will be sent to all
participating physician offices to
replace the seed packets in the waiting

room displays.

For more information or to participate,
please call WomanCare at 402-3800.

)
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Neurophysiology Lab Extends Hours
The Lehigh Valley Hospital
Neurophysiology Laboratory is
dedicated to meeting the growing needs
of the community. Therefore, in order
to provide more convenient service for
your patients, beginning May 10, the
hours for outpatient services will be
extended.
New hours for the Neurophysiology
Laboratory at Cedar Crest & 1-78 are
Monday, Tuesday, Wednesday, and
Friday from 7 a.m. to 5:30p.m.;
Thursday from 7 a.m. to 8 p.m.; and
Saturday from 8 a.m. to 2 p.m.
The hours for the laboratory at 17th &
Chew will remain the same - 8:30
a.m. to 4:30p.m., Monday through
Friday.
Services currently available for
pediatric and adult patients include:
o Electroencephalography (BEG)
-Routine
- Sleep/Awake - with Anterior
Temporal Leads

o 24° Ambulatory Monitoring (BEG)
o Long Term Video Monitoring (BEG)
o Brainstem Auditory Evoked
Potentials
o Visual Evoked Potentials
o Somatosensory Evoked Potentials
- Upper & Lower Extremities, OR
Monitoring
o Visual Fields Testing
o Multiple Sleep Latency Testing

(MSLT)

o EMGINC Testing
o Botulinum Toxin Injections (Botox)
- for treatment of Dystonia
(Torticollis, Blepharospasm,
Hemi-facial Spasm, and focal
limb Dystonia)
o Autonomic Testing
For additional information or
scheduling, please call the
Neurophysiology Laboratory at 4028860 (Cedar Crest & 1-78) or 402-2297
(17th & Chew).

News from Home Care
Richard Steigerwalt has returned to the
Lehigh Valley Hospital family as
Physical Therapy Manager of Lehigh
Valley Home Care. Many of you may
remember Dick, who has 32 years
experience in physical therapy. Prior
to the hospital merger, Dick was Chief
of Physical Therapy from 1962 to 1969 .
at Allentown Hospital, Director of

Physical Therapy from 1970 to 1974 at
Allentown Hospital, and Director of
Physical Therapy at Lehigh Valley
Hospital Center from 1974 to 1984.
During the last nine years, Dick has
served as Director of Physical Therapy
at Palmerton Hospital. Welcome back!

)
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Legal
Briefings

Frequently, the Department of Legal
Services/Risk Management receives
telephone requests for information
from the Medical Staff related to legal
issues, ethical concerns, risk
management, and insurance questions.
In response to these requests, this
column will appear in Medical Stqff
Progress Notes every other month.
Your input and questions are welcome.
Insurance policy questions are a
frequent area of concern. Good advice
includes re-reading your policy at least
once a year to make sure it covers you
for what you actually do. If you are
changing insurance companies, you
may want to call the State Insurance
Department for information about the
solvency of the company. A new
company offering lower rates to secure
your business may be placing
themselves at a high risk (and you
also, if the company folds just when
you need them!). You may also want
to check the rating assigned by Best.
In assigning letter grades to each
company, consideration is given to
assets, management, loss reserves, and
profitability. Obtaining a copy of the
company's financial statement is also
helpful. Check to see if it is certified
by one of the national accounting
firms. Ask your own accountant to
look at it to see if the carrier's reserves
seem adequate. Find out if the
company is backed by the State
Guaranty Fund, which pays claims
against insurers if the company goes
bankrupt. Check with your colleagues
to find out what kind of service you
will receive after you are sued. You
should determine what your rights are
in choosing counsel if you are sued.

Pennsylvania, you generally do not
have to be concerned about deciding
how much insurance you should carry.
The primary limits will be provided as
required by state law, and of course,
every health care provider in
Pennsylvania also has a million dollar
secondary layer provided by the CAT
Fund. (The Medical CAT Fund is not
to be confused with the Automobile
CAT Fund.)
Most malpractice policies today are
claims-made, this pays only if the
incident occurs and the claim is
brought within the policy period. If
you leave a claims-made policy, you
may need to buy a tail, which can cost
as much as six times the cost of your
last years premium. It is vitally
important that you notify the carrier as
soon as you become aware of a
potential claim. Many policies do not
cover libel and slander, intentional,
criminal, grossly negligent acts, as
well as sexual misconduct.
If your carrier doubts that a particular
claim should be covered, they will

send you a "Reservation of Rights"
letter. Your defense will continue, but
the carrier may refuse to pay the
ultimate judgment. If you receive such
a letter, you should inform your
personal attorney immediately.

Since the limits of insurance coverage
are actually state mandated in
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In an effort to provide you with
nutrition information which may
benefit your patients, this column will
appear in the newsletter regularly.

Clinical

1Nutrition
News

•

.,

The Prudent Diet

by Barbara Carlson M.S., lt.D.

How many inpatients are educated on
the prudent, low fat, low cholesterol
diet every month at Lehigh Valley
Hospital? The answer: over 200
individuals receive education on this
diet prior to discharge.
Looking toward the future, however,
clinical dietitians, along with all other
hospital departments, anticipate shorter
patient stays. Shortened patient stays
will require more rapid education and
intervention. The short time
constraints will require diet education
to be accomplished when patients are
still acutely ill and unable to fully
comprehend their diet.
However, the clinical dietitians have a
strong desire to provide quality
education with useful, workable
guidelines and goals which will give
patients the information needed to
modify their diet after they leave
Lehigh Valley Hospital.
The Clinical.Nutrition Department
decided to try a new approach toward
cardiac diet education. Beginning
April 12, an early evening class for
cardiac patients and their families was
initiated. The class is offered from
6:30 to 7:30p.m., two Monday
evenings each month.

)

their hospital stay. Family members
and caretakers are welcome and
encouraged to attend.
Topics covered in the class include:
o

o

o
o

o

o

selecting a diet with 20% or
less of the calories from fat
(under 7% saturated)
limiting cholesterol to 175mg

per day or less
increasing dietary fiber and
decreasing simple sugars
the relationship of blood lipids
(cholesterol and triglycerides) to
coronary artery disease and
current knowledge about diet
control
interpreting food ·labels
correctly
dining out and special occasions

This class is free of charge to any
patient referred by a member of Lehigh
Valley Hospital's Medical Staff. A
prescription slip should be sent with
the patients you refer. Notification
will be sent to your office after your
patient attends the class.
A brochure describing the class, dates

offered, and reservation information is

available through Clinical Nutrition
Services. For copies of the brochure
or if you have any questions regarding
this new class, call the Clinical
Dietitians's Office at 402-8313.

The one-hour class is available and
appropriate for patients prior to
admission, after discharge, or during
PageS

Short Stay Unit Changes Name
Effective May 8, the Short Stay Unit
changed its name to 3C with the
implementation of PHAMIS I..astWord.
All signs will be changed to reflect 3C.
Patient location in the LastWord
system will be 3C plus the room
number, i.e., 3C11A.

If you have any questions, please
contact Julia Clelland, Director, Patient
care Services, 3C, at 402-8228.

News from Research
Calls for abstracts have been issued by
the American College of
Gastroenterology for the 58th Annual
Scientific Meeting to be held in New
York on October 4, 1993. Submission
due date is May 31.

For instructions, forms, and further
information, contact Kathleen Moser in
the Research Department at 402-8889.

Letters of Appreciation

)
Page 10

Congratulations!
Jeffrey L. Gevirtz, M.D., urologist,
was recently informed that he
successfully completed all the
requirements for certification and is
now certified as a Diplomate of the
American Board of Urology.

Lester Rosen, M.D., colon-rectal
surgeon, has been appointed to a twoyear term as an Associate Examiner by
the American Board of Colon and
Rectal Surgery. As an Associate
Examiner, he will be involved in all
aspects of the examination process for
board certification in colon and rectal
surgery, including preparation of test
items for the written examination and
participation in the oral examination.

Dolores M. Sarno-Kristofits, Ph.D.,
psychologist, successfully completed
her doctorate at Temple University.
The title of her dissertation is
Ericksoulan Psychosocial Stqes of
Development and its Relatio:nsbip to
Post-Traumatic Stress Syndrome.
Edward A. Tomkin, D.O.,
otolaryngologist, was recently certified
in Otorhinolaryngology and Facial
Plastic Surgery by the American
Osteopathic Board of Ophthalmology &
Otorhinolaryngology.

Publications, Papers and Presentations
Glen L. Ollver, M.D., ophthalmologist, recently attended the fourth
meeting of the Schepens International
Society jointly organized with the
Chinese University of Hong Kong in
Hong Kong. He presented a 27-year
follow-up of the Oliver-McFarlene
Syndrome (Congenital Trichomegaly
with Associated Dwarfism, Pigmentary
Retinal Degeneration, Mental
Retardation and Cerebellar
Degeneration). Nine other cases have
now been reported in the literature.
Evidence of axonal peripheral
neuropathy and cerebellar degeneration
was found in this patient and its
development should be anticipated
when the syndrome is recognized in
younger people.

)

Dr. Oliver also co-authored an article,
Necrotic Orbital Melanoma Arising
De Novo, which was published in the

February, 1993 issue of the British

Journal of OphtluJlmology.
Robert B. Kevitch, M.D., plastic and
reconstructive surgeon, participated in
a panel discussion as part of a program
entitled Breast Health in the 90's.
The program took pl8ce in East
Stroudsburg and was sponsored by the
American Cancer Society.

lndm T. Khubchandani, M.D.,

colon-rectal surgeon, was invited to
participate in a Round Table on
Compllc:atious in DJaestive Stoma at
the First World Ostomy Congress for
Health Professionals in Madrid, Spain,
on Apri113 to 16. The meeting was
organized by the Spanish Ostomy
Association with International
Cooperation from World Health
Organization (WHO) and International
Ostomy Association (lOA).
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Upcoming Seminars, Conferences, and Meetings
Medical Grand Rounds
Rheumatic Fever in the 90's and Post
Streptococcal Diseases will be
presented by Donald D. Goldsmith,
M.D., Professor of Pediatrics, Temple
University School of Medicine, and
Director of Rheumatology, St.
Christopher's Hospital, Philadelphia,
on Tuesday, May 18.
Non-Steroidals in the Elderly will be
presented by John DiGreggorio, M.D.,
Professor of Pharmacology and
Medicine, Hahnemann University,
Philadelphia, on Tuesday, May 25.
Medical Grand Rounds are held on
Tuesday of each week beginning at
noon in the Auditorium of Lehigh
Valley Hospital, Cedar Crest & 1-78.
For more information, contact the
Department of Medicine at 402-8200.

Department of Pediatrics
Members of the faculty of St.
Christopher's Hospital for Children,
Philadelphia, will participate in the
Pediatric Symposium on Thursday,
May 20, from 1 to S p.m., in the
Auditorium of Lehigh Valley Hospital,
Cedar Crest & 1-78. Topics and
speakers include What's New in the
DiGeoqe Syndrome to be presented
by Angelo DiGeorge, M.D.; Chrome
Pain in ChUdren and Adolescents by
David Smith, M.D.; and Kidney
Transplants in ChUdren: l l Years'
Experience by H. Jorge Baluarte,
M.D. Waldo Nelson, M.D., will
serve as Panel Moderator.

Update on Urioary Tract Infectious
will be presented by Charles Reed,
M.D., Chief, Section of General
Pediatrics, St. Christopher's Hospital
for Children, on Friday, June 4, at
noon.

Case ·Presentations in Pediatric

Emer&enc:ies will be presented by

Douglas Baker, M.D., Division of
Emergency Medicine, Children's
Hospital of Philadelphia, on Friday,
June 18, at noon.
All conferences, except the Pediatric
Symposium, will be held in the
Auditorium at 17th & Chew.

For more information, contact Beverly
Humphrey in the Department of
Pediatrics at 402-2410.

Psychiatric Grand
Rounds
Review of the Catatonic Syndrome
will be presented by Gregory
Fricchione, M.D., Department of
Psychiatry, Health Sciences Center,
State University of New·York at Stony
Brook, on Thursday, May 20, at noon,
in the Auditorium of Lehigh Valley
Hospital, 17th & Chew.

As lunch will be provided,
preregistration is requested. For more
information or to register, call Lisa in
the Department of Psychiatry at
402-2810.

)
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• For Sale or Leae - Springhouse
ProfealoMI c..t •• 1575 Pond Road. Ideal
for phyllc:IM's office. Approxlmetely 2,500
sq. ft. Wll finish spece to specifications.
• For Sale or Leae - Medlcal-profealoMI
office building on South C... Crest
Boulftn, just mhlt• tram Ceder Crest • 1-

78 8lld 17th. Chew. 3,580 tOUIIsq. ft.
Ample pMdne. ucurltylftre alarms Installed.
Ideal for .,...,.._. group.

• For Sale - Office building et Northeat
c:onw of 19th 8lld T..,... Streets In
Alentown. UPI* level- 2,400+ sq. ft., large
welting room, two a.ge COR8Uitatlon rooms.
five uem rooms. etc. Low• level - 2,300 +
sq. ft. Perking lot for 18 '*-·

• For Leae - Medical office space located In
Southeest Allentown ....- Mounulnvlle
Shopping Cent•.
• For Leese - Slota . . currently ..,....,._ for
the Brown Beg suite et Kutztown Profeulonal

C..t•.

• For Leae - SMre l•ge medical office n. .
Ceder Crest • 1-78. Fuly fumllhed llld
staffed. Multiple lne phone ~em.

Computerized . . . . ..,....,..,

• For Leae - Spec:llfty prectlce tlme-stwre
spece ..,....... In • comprehensive heelth
fedlty. . . . . . . . Profenlonel en.. 4019
Wymewood Drive. Leurya Stetlon. Helf- or

-=-•

ful.dey llotlllmrnedletely ..,.........

• For Leae - Medlcel office space located In
Puchtree Office Plue In Whltehell. One suite
with 1 ,500 sq. ft. (Wiflnlthed - allowance
avellableJ, and one 1,000 sq. ft. finished suite.

• For L...e - Shere spece In MOB 1 on the
campus of Lehigh Veley Hospital. Ceder Crest
• 1-78. Approxlmetely 1 ,000 sq. ft. Three

• For LeMa- Medlcel-prof•slonel office
spece located on Route 222 In W•cosvlle.
Two 1 ,000 sq. ft. offices available or combine
to form l•ger suite.

For more lnformetlon or for •~ce In
finding epproprlllte office spece to meet your
needs, contect Joe Pile, POPS Rep, et

WHO'S NEW

Daniel M. Rappaport, MD
Mishkin, Rappaport, Shore
3321 Chestnut Street
Whitehall, PA 18052
(215) 262-7123

The Who's New section of Medical
Skiff Progress Notes contains an
update of new appointments, address
changes, newly approved privileges,
etc.
Please remember that each department
or unit is responsible for updating its
directory, rolodexes, and approved
privilege rosters.

Medical Staff
Change of Address
Domenic M. Falco, DO
Emaus Avenue Family Practice
1101 W. Emaus Avenue
Allentown, PA 18103

exam rooms.

402-9856.

(Effective June 1, 1993)

Jo-Anne A. Steward, MD
Fogelsville Medical Associates
7671 Schantz Road
P.O. Box 952
Fogelsville, PA 18051-0952
(215) 395-3400
Lehigh Valley Medical Associates
(James T. McNelis, DO, Michael R. Goldner,

DO, and John M. Kauffman, Jr., DO)

1255 S. Cedar Crest Blvd.
Suite 2200
Allentown, PA 18103
(Effective June 11, 1993)

Continued on Page 14
Page 13

Continued from Page 13

Appointment of Medical
Director - Ambulatory
Pediatrics
Cbarles F. Smith, MD

Additional Privileges
1bomas D. Meade, MD

Department of Surgery
Division of Orthopedic Surgery
Section of Orthopedic Trauma
Endoscopic Carpal Tunnel Release
Privileges

Daniel M. SUverbeq, MD
Department of Surgery
Division of Urology
YAG and C~ Laser Privileges
F. Geoffrey Toonder, MD
Department of Surgery
Division of Cardio-Thoracic Surgery
Video Assisted Thoracic Surgery and
Thoracoscopy Privileges

Change of Status
Joseph J. Prorok, MD
Department of Surgery
Division of General Surgery
From Active/LOA to Honorary

Resignation
Roberta B. Gonzalez, MD
Department of Psychiatry

Allied Health
Professionals
Appointments
1bomas W. Lane, PbD

Associate Scientific
Psychologist

(The Guidance Propam)

Beverly C. Woodward, RN
Physician Extender
Professional - RN
(Falnily Pecliatriciaoa - Dr. Kean)

Change of Category
Elizabeth D. Hawley
Physician Extender
Technical to Professional
Dental Assistant to Dental Hygienist

Jane L. Kulhamer

Physician Extender
Technical to Professional
Dental Assistant to Dental Hygienist
'

Supervising Physician
Changes
~na

M. Filla, RN

Physician Extender
Professional - RN

(ramar D. Baroelt, MD)

Change Alternating Supervising
Physician from Alan Berger, MD to
Linda Lapos, MD

Ruben P. Romero, PA-C
Physician Extender
Physician Assistant
(F. Geoffrey TOODder, MD)

Add Substitute Supervising Physician -

Nercy 1afari, MD
Continued

on Page 16
Page 14

Continued from Page 14

Resignations
Mary Ann Butler, RN
Physician Extender
Professional - RN
(Mahmood A. Tahir, MD)

Diane C. Fabiani, CMA
Physician Extender

Technical
Medical Assistant

(Children'a HealthCare)

Jean E. F1sc:ber, PA-C
Physician Extender
Physician Assistant
PA-C

(F. Geoffrey Toonder, MD)

Greta Flederbach, PA-C
Physician Extender
Physician Assistant
PA-C
(Levine and Busch, PC)

Sheri L. Fredrick-Deeb, RN
Physician Extender
Professional - RN
(Cardiology Care Specialists)

Richard R. Grabowski, PbD
Associate Scientific
Audiologist
Gretchen C. Gray, RN
Physician Extender
Professional - RN
(Gregory M. Lang, MD)

CllrWtine S. BDienbrand, CMA
Physician Extender
Technical
Medical Assistant
(Children's HealthCare)

Patti A. Hutehiawn, RN
Physician Extender
Professional - RN
(Concepcion Tan Yen, MD)

Mary-Lou T. Mayernick, RN
Physician Extender
Professional - RN
(Iohn J. Cauel, MD)

JUI D. Moyer, RN
Physician Extender
Professional - RN

(Valley OB-GYN Associates)

Sharon K. Gable
Physician Extender
Technical
Dental Assistant

(David H. Packman, DDS)

Vldd L. Givler
Physician Extender
Technical
Medical Assistant
(Lehigh OB/GYN, PC)
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P&T Highlights
The following actions were
taken attha April12, 1993,

Pharmacy and Therapeutics
Committee Meeting
James A. Giardina, Diractor
of Pharmacy

Fonnulaty Considerations
Strrmp- tbtm Wbtlt1

Oral Ketorolac (I'orrttiDI, SyRia-) was discussed
fur fOrmulary addition. Key data discussed were
its lack of advantage in clinical trials over the 10
other NSAIDs on funnulary and its cost relative
to other NSAID'S. Ketorolac produces similar
pain relief to ibuprofen, naproxen and diilunisal in
trials in post-op orthopedic and dental and oral
surgery procedures. Table 11ists some key
comparative data.
Oral Oadanletron (ZDfrM, Glco) -is the oral
funn of the previously approved injectable
antiemetic. Oral ondansetroo is indicated fur the
prevention of nausea and vomiting associated with

Aspirin•

500-lOOOmg

Q4-&H

500-UXXJmg
200-800mg

Q4-&H

«XJJmg

IUl5

Q4-8H

3200mg

*».13

Acetaminophen

Tylenol

Ibuprofen

Motrin

Naproxen

Naprosyn

500mg initial,
then
250-375mg

Q6.8H

1500mg

ll.20
$3.36

Naproxen
Sodium

Anaprox

550mg initial,
then 275mg

0&-8H

1375mg

$2.70

Oiclofenac

Voltaren

25-75mg

Q6.8H

200mg

$2.96

Indomethacin

lndocin

25-50mg

08-12H

200mg

1).12

Oiflunisal

Dolobid

1000mg initial,
then 500mg

08-12H

1500mg

$2.60

Nabumetone

Relafen

1000mg initial,
then 500mg

Q12-24H 2000mg

$1.50

Piroxicam

Feldene

10-20mg

Q12-24H 20mg

$1.40

kulindac

Clinoril

Q12H

400mg

1).40

Tolmetin

Tolectin

2000mg

$3.90

KETOROlAC PO

TORAOOL

. 150-200mg •
200mg-400mg

08H
0811

• Aspirin in higher doses may be used for rheumatic diseases.

...

sus

moderately emerogenic cancer chemotherapy.
Ondansetron inhibits 5-HT1 Receptors and
appears to block serotonin in the area posttema of
the brain, the gut, and/or other regions of the
central nervous system. Oral bioavailability is
60% with peale levels seen in 1.5 hours and half
life of 3-6 hours. Ondansetron is extensively
metabolized via the Cyux:hrome P-450 System.
Studies to date have compared it only to placebo
in various chemotherapy regimens. The most
common adverse drug reactions include headache, diarrhea and coostipation.

The recommended oral dose is 8mg given 30
minutes befOre emetogenic chemotherapy and
subsequent doses 4 and 8 hours after the first
dose. It should then be given as 8mgTID fur 1-2
days after completion of chemotherapy.
Ondansetron has not been studied in renal
patients. The total dose should not exceed 8mgl
day in severe hepatic insufficiency.
The cost of8mg ondansetron is $15 .00/tablet
(yes, you did read it axrectl.y). The Committee
requested that usage guidelines be developed to
assure appropriate use.
Parmetine (P.U, SKB) - is the latest Selective
Serotonin Reuptake Inhibitor (SSRI) to be
approved. It is indicated fur the treatment of
depression. Paroxetine is more potent and more
selective than either Buoxetine or senraline.
Parmretine is well absorbed although availability is
reduced due to first pass metabolism. Paroxetine
has a half life of 12-20 hours; is highly protein
bound (95% ), and metabolized to essentially
inactive metabolites prior to excretion in the urine
and feces. There appears to be wide interpatient
phannacokinetic variability due primarily to the
existence of exten5ive and poor metabolizers.
This vuiabil:ity is also obsenred in renal impaired
and cirrhotic patients and dosages should be
adjusted. UnliJce Buoxetine, Paroxetine is
excreted in pharmacologically significant quantities in breast mille. Therefure it should not be
Page 17

Formulary Considerations
Conlillllll ........ ,

used in breast feeding women.
Commoo side effects are similar to other SSRis.
Parmetine appears 1D cause more sedation and
amstipation than other SSRis and mere headache
and dry mouth than fluoretine (similar to
senraline). Parozetine causes less anorexia than
flUOllletine. When rakm at night, Parmetine has
caused some sleep disturbances. Consequently,
the dose should be rakm earlier in the day. Drug
intenctions include MAO inhibitors .(significant).
and agents metabolized by the Cytnchrome P450 System (cimetidine. phenytoin.
phenObamtal, wufirin, etc.). Patients should
have a two week free intenal between Parmetine
and MAOI therapies. The usual starting dose is

20mg daily. Doses may be adjusted upward in
10mg increments no more often than weekly to
SOmg/day. With the addition ofParoxetine and
apparent shift away &om Trilfet:racyclics. the
Conunittee asked Psychiatry to review these
apnts fDr possible formulary deletions.
Parmetine oosts $1.S0/20mg tablet.
Dyprota (Blirlc&) - is a combination product
cmClining nne oxide, peaolatmn and other
protectants used to prevent/treat diaper rash. .
Dyprotex bas similar ingredients to Desitin and is
used similarly. Dyprou:x oomes in individual
applicaur packages. Dyprou:x was added to the

fOrmulary.

Drug Use Evaluation
Ifthe Gilt Wtris•••••.• U.wlt!

Famotidi.ae IV to PO - Results from a two
month study to couva t injectable famotidine to
oral therapy in patients currently receiving at least
2 scheduled oral meds were discussed. Ow-t
requests were used to SIJ8FSt conversion in

200mg

500mg

Q12H

$13.00

$2.10

750mg

Q12H

$25.00

$2.40

Editor's Nots: The intrn1111ous route for bath t.motidine 1nd ciprotiDKICin should
only be used when thllf'fl 1re contrlindicltions to Ofll therlpy. Effic1cy is no
gre1ter for either mediCition when gillen IV. Also, both medicltions m1y be
crushed 1nd 1dministered vii feeding tubes (i.e., NG, Dobhoff, etc.} if Gl
1bsorption is felt to be 1dequ1te.
·

appropriate patients. A total of91 (69%) out of
131 identified patients were axwerted. 70 (53%)
were changed from IV to PO, 20 (16%) had
orders fDr either route and were converted to PO.
An additional24 (18%) had therapy discontinued
- this later group was not included in the 69%
cmvenion. Drug acquisition savings alone
amount to $8000 annually. Hother supply and
labor oosts were included, the savings would
nnge to $24,000.
CiprofloDcia IV to PO - IV Ciprofloxacin
patients who have had no apparent
cmtnindications to oral therapy were also
targeted for conversion requests. While the total
number of eligible patients (18) and number of
successful conversion (12) were smaller, the
savinas were also around $8,000 annually given
the large cost difference between the PO and IV
furms. See Table 2.
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Target Antibiotics
Ceftazidime

High empiric use (13%) continues although average length
oftheraPV (LOT) has decreased.
IIBcomtnendation~ Csftuidime is tlt:ommended to trelt
gflm negative ucH/i in cefuolin tlli6t6nt pstientl or to
trest pseudomon11 when piper~cilin is not sppropriltl
(sllergy, resistsnceJ.

Ciprofloxacin

High empiric use continues (77%) also with decreased LOT.

Recommend6tions - IV ciproflo1t1cin use should be limited
to ruismnt 111Dbic gram-neg1tive ucilli (e.g.
Poudomon•s. Entllroblt:tflr, s.n.ti1}. Orll therspy should
be considered in 111 pstients with 1 functioning Gl trlct
Ampicillin/
Sulbactam
(Surgical 1
Prophytaxis only)

Only 7 cases were reviewed. Data showed pre-op given in
patient care areas. LOT ranging from 1 dose to 10 days
(ave. 3.5 days) and majority with no documentation of need
(+specimen.+ complications,+ signs of infection post-op).
Recommendstion~ The 11'1iew liteflfllfl generally
flt:ommends cef1zolin for mOlt surgic1l procedutl&
Csfuolin/MIItroniiMzole or Cefotetln (2nd generation} ,,.
11commended for prophyii1Cis in surgic11 ,,., whtfl
Bnserobes msy be present M1ny references now
11commend one doss 111tt:ept in prolonged oper6tions
sndlor csrtsin proceduru. The pre-op dOSB should be
given within 2 hours of incision.

Data from March, 1993 were presented. Areas of
b:us were Ceftmdine, Oprofloxac:in and
Ampic:illin/Sulbac:tam. Ampicillin/Sulbactam
usage review was limited to surgical prophylaxis
cases only.

Temporary Shortage of
Hydralazine

The Committee was informed that IV
Hydnlazine is pnerally unavailable due to the
discontinuation of production by one of the only
two manu&cturers. Alternative agents should be
CXXISidered if at all possible until the shortage ends
(hopefully May, 1993).

The Committee recommended that a more comprehensive review of surgical
prophylaxis be conducted.

)
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